The Scientist

» clinical trials and immunology

Most Recent

image: More than 40 New Papers on Epigenetics Published

More than 40 New Papers on Epigenetics Published

By | November 22, 2016

The International Human Epigenome Consortium presents a series of studies on how epigenetics influences immunity, cell lineage determination, and differentiation.

0 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

image: Contributors

Contributors

By | November 1, 2016

Meet some of the people featured in the November 2016 issue of The Scientist.

0 Comments

image: Nosing Around

Nosing Around

By | November 1, 2016

Covering neuroscience research means choosing from an embarrassment of riches.

0 Comments

image: Viruses of the Human Body

Viruses of the Human Body

By | November 1, 2016

Some of our resident viruses may be beneficial.

4 Comments

image: Immune System Maintains Brain Health

Immune System Maintains Brain Health

By | November 1, 2016

Once thought only to attack neurons, immune cells turn out to be vital for central nervous system function.

3 Comments

image: Immunity in the Brain

Immunity in the Brain

By | November 1, 2016

Researchers document the diverse roles of immune cells in neuronal health and disease.

0 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

image: European Drug Regulator Releases Clinical Trial Data

European Drug Regulator Releases Clinical Trial Data

By | October 21, 2016

In the initial steps of a campaign to make clinical reports publicly available, the European Medicines Agency has published data on two recently approved drugs.

0 Comments

image: Culprit for Antibody Blockade Identified

Culprit for Antibody Blockade Identified

By | October 21, 2016

Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.

0 Comments

Popular Now

  1. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  2. Man Receives First In Vivo Gene-Editing Therapy
  3. Researchers Build a Cancer Immunotherapy Without Immune Cells
  4. Child Receives Transgenic Skin Over Most of His Body
RayBiotech